首頁 > 市場調查報告書 > 製藥

動物用醫藥

獸用人工授精市場規模、佔有率和成長分析（按動物類型、產品、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900758

獸用人工授精市場規模、佔有率和成長分析（按動物類型、產品、最終用戶和地區分類）－2026-2033年產業預測

Veterinary Artificial Insemination Market Size, Share, and Growth Analysis, By Animal Type (Cattle, Ovine Caprine), By Product (Equipment & Consumables, Semen), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 154 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，獸用人工授精市場規模將達到 83.4 億美元，到 2025 年將達到 88.7 億美元，到 2033 年將達到 145 億美元，預測期（2026-2033 年）的複合年成長率為 6.34%。

受多種關鍵因素的驅動，獸用人工授精市場正在成長，這些因素包括對永續食品生產的需求、性別選擇精液的應用以及提高動物生產力的需要。這一趨勢反映了肉類、牛奶和乳製品消費量的成長。獸用人工授精服務的日益普及至關重要，因為專業機構專注於各種動物的人工授精程序，並透過專業的精液採集和處理來提高受孕率。繁殖管理計劃是這些服務的補充，為育種者提供全面的策略來指導其完成整個繁殖週期。這些服務通常包括發情同步、生育力測試、超音波和生殖健康評估，所有這些都有助於提高受孕率、最佳化繁殖效率，並最大限度地減少育種者和寵物飼主可能遇到的繁殖併發症。

全球獸用人工授精市場依產品種類、動物種類、技術、應用及地區細分。按產品類型分類，市場分為設備和耗材以及精液。依動物種類分類，市場分為牛、豬、牛、山羊、馬和其他動物。依技術分類，市場分為子宮內授精、輸卵管授精、腹腔內授精、子宮頸內授精、子宮內授精及輸卵管內授精。按最終用戶分類，市場分為獸醫診所、畜牧場和其他。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

獸用人工授精市場促進因素

獸用人工授精市場的主要驅動力在於其能夠促進安全可控的育種計劃，從而有效遏制動物群體中疾病的傳播。這項技術透過使用來自無病或抗病牛的精液，最大限度地降低了感染疾病傳播給後代的風險。此外，它還可以透過消除動物在配種過程中的直接接觸，有助於疾病預防。而且，使用經過健康檢測的牛的精液對母牛進行人工授精的做法，符合疾病根除工作的要求，並有助於逐步消除群體中的疾病。這項技術使育種者能夠利用抗病牛品系的可靠精液，選擇性地培育出具有更強抗病能力的品種。

獸醫人工授精市場的限制

獸醫人工授精市場面臨的一大障礙是先進技術和設備的高昂成本。精準育種技術，例如使用性別選擇精液和先進的生殖技術，都需要大量投資。獸醫診所和農場在購買設備、維護以及有效實施這些技術所需的培訓方面都面臨著高昂的成本。因此，許多營業單位，特別是小規模企業和發展中地區的機構，可能對採用和使用先進的人工授精方法猶豫不決。這種經濟挑戰可能會阻礙市場擴張，並導致各行業的採用率較低。

獸用人工授精市場趨勢

獸用人工授精市場正呈現顯著的趨勢，即整合先進的基因技術。基因組學和基因選擇工具等創新技術正被擴大用於最佳化性狀選擇，從而提高育種效果。特別是，使用性別選擇精液能夠生產出所需性別的後代，而基因組學技術的進步也有助於提高牲畜的遺傳品質。這些技術進步顯著提高了育種計劃的效率和牲畜的整體生產力。隨著這些先進基因解決方案的不斷普及，我們預期獸用人工授精市場將進一步成長和發展。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

URUS Group LP
Genus
CRV
Semex
IMV Technologies
Select Sires Inc
Swine Genetics International
Shipley Swine Genetics
Stallion AI Services Ltd
STgenetics
Strategy Mapping
Kruuse Ltd.
AgTech Inc.
Boehringer Ingelheim
Elanco Animal Health
Bovine Elite LLC
ABS Global Inc.
Santa Cruz Biotechnology
Neogen Corporation
Iherdsman

結論與建議

簡介目錄

Product Code: SQMIG35A2962

Veterinary Artificial Insemination Market size was valued at USD 8.34 Billion in 2024 and is poised to grow from USD 8.87 Billion in 2025 to USD 14.5 Billion by 2033, growing at a CAGR of 6.34% during the forecast period (2026-2033).

The Veterinary Artificial Insemination market is experiencing growth driven by several key factors, including the demand for sustainable food production, the application of sexed semen, and the need for enhanced animal productivity. This trend reflects the rising consumption of meat, milk, and dairy products. Increased adoption of Veterinary artificial insemination services is crucial as professional providers specialize in AI procedures across various animal species, enhancing conception rates through expert semen collection and processing. Reproductive management plans complement these services, offering comprehensive strategies to guide breeders through the breeding cycle. Services typically include estrus synchronization, fertility testing, ultrasound exams, and reproductive health assessments, all of which significantly help breeders and pet owners improve conception rates, optimize reproductive efficiency, and minimize reproductive complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Artificial Insemination Market Segments Analysis

Global Veterinary Artificial Insemination Market is segmented into product, animal type, technique, end use, and region. By Product, the market is segmented into Equipment & Consumables, and Semen. By animal type, the market is segmented into Cattle, Swine, Bovine, Ovine Caprine, Equine, and Other Animals. By technique, the market is segmented into Intrauterine tub peritoneal insemination, Intracervical insemination, Intrauterine insemination, Intratubal insemination. By end user, the market is segmented into veterinary hospitals, animal husbandry, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Veterinary Artificial Insemination Market

The Veterinary Artificial Insemination market is significantly driven by its ability to facilitate safe and controlled breeding programs, which effectively mitigate the spread of diseases among animal populations. This technique minimizes the risk of transmitting infections to offspring by allowing breeders to utilize semen from sires confirmed to be disease-free or resistant. The method also helps prevent epidemics by eliminating direct contact between animals during breeding. Furthermore, the practice of inseminating females with semen from health-tested sires aligns with disease eradication initiatives, supporting the gradual elimination of illnesses from the population. This technology empowers breeders to selectively breed for enhanced disease resistance using trusted semen from resilient sire lines.

Restraints in the Veterinary Artificial Insemination Market

A significant barrier to the veterinary artificial insemination market is the considerable cost associated with advanced technology and equipment. Precision breeding techniques, such as the use of sexed semen and sophisticated reproductive technologies, demand substantial investment. Veterinary practices and farms face high expenses related to purchasing machinery, its upkeep, and necessary training to implement these technologies effectively. As a result, many businesses, particularly smaller firms and those in developing regions, may be deterred from embracing and utilizing advanced artificial insemination methods. This financial challenge can hinder market expansion and lead to minimal adoption rates across various segments.

Market Trends of the Veterinary Artificial Insemination Market

The veterinary artificial insemination market is witnessing a notable trend towards the integration of advanced genetic technologies. Innovations such as genomics and genetic selection tools are increasingly being utilized to refine trait selection, leading to improved breeding outcomes. Notably, the use of sexed semen allows for the production of preferred offspring genders, while genomic advancements contribute to enhanced genetic quality in livestock. These technological enhancements have significantly increased the efficiency of breeding programs and overall livestock productivity. As the adoption of these advanced genetic solutions continues to expand, further growth and evolution in the veterinary artificial insemination market are anticipated.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis

Global Veterinary Artificial Insemination Market Size by Product & CAGR (2026-2033)

Market Overview
Equipment & Consumables
Semen
- Normal
- Sexed

Global Veterinary Artificial Insemination Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Bovine
Swine
Ovine & Caprine
Equine
Other Animals

Global Veterinary Artificial Insemination Market Size by Technique & CAGR (2026-2033)

Market Overview
Intrauterine tub peritoneal insemination
Intracervical insemination
Intrauterine insemination
Intratubal insemination

Global Veterinary Artificial Insemination Market Size by End user & CAGR (2026-2033)

Market Overview
Veterinary Hospitals
Animal Husbandry
Others

Global Veterinary Artificial Insemination Market Size & CAGR (2026-2033)

North America, (Product, Animal Type, Technique, End User)
- US
- Canada
Europe, (Product, Animal Type, Technique, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Animal Type, Technique, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Animal Type, Technique, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Animal Type, Technique, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

URUS Group LP
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Semex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMV Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Select Sires Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swine Genetics International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shipley Swine Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stallion AI Services Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STgenetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strategy Mapping
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kruuse Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgTech Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bovine Elite LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABS Global Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santa Cruz Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iherdsman
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments